Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000561673 | SCV000675721 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-09-11 | criteria provided, single submitter | clinical testing | The p.K125N variant (also known as c.375G>C), located in coding exon 4 of the TSC2 gene, results from a G to C substitution at nucleotide position 375. The lysine at codon 125 is replaced by asparagine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001295259 | SCV001484174 | benign | Tuberous sclerosis 2 | 2023-06-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001295259 | SCV002040544 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000561673 | SCV002533448 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-10 | criteria provided, single submitter | curation |